Scientists create an scRNA-seq atlas of the multiple myeloma immune microenvironment across disease stages

byVIB (the Flanders Institute for Biotechnology)The MM microenvironment is characterized by the presence of T cells with an exhausted phenotype. Credit:Journal of Hematology & Oncology

Updated on: December 02,2024 0

Scientists create an scRNA-seq atlas of the multiple myeloma immune microenvironment across disease stages

byVIB (the Flanders Institute for Biotechnology)The MM microenvironment is characterized by the presence of T cells with an exhausted phenotype. Credit:Journal of Hematology & Oncology

Updated on:December 02,2024 0

Research highlights breast cancer risk for female firefighters

bySilent Spring InstituteCredit: Pixabay/CC0 Public DomainIt's well documented that firefighters have significantly higher rates of cancer than the general population, and these elevated rat

Updated on: December 02,2024 0

Research highlights breast cancer risk for female firefighters

bySilent Spring InstituteCredit: Pixabay/CC0 Public DomainIt's well documented that firefighters have significantly higher rates of cancer than the general population, and these elevated rat

Updated on:December 02,2024 0

New therapeutic vaccine gives hope against an aggressive breast cancer

by Dennis ThompsonAn experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.The vaccine appears to be safe and

Updated on: December 02,2024 0

New therapeutic vaccine gives hope against an aggressive breast cancer

by Dennis ThompsonAn experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.The vaccine appears to be safe and

Updated on:December 02,2024 0

Neoantigen DNA vaccine shows promise against aggressive breast cancer in clinical trial

by Julia Evangelou Strait,Washington University School of MedicineA small clinical trial conducted at WashU Medicine shows promising results for patients with triple-negative breast cancer who r

Updated on: December 02,2024 0

Neoantigen DNA vaccine shows promise against aggressive breast cancer in clinical trial

by Julia Evangelou Strait,Washington University School of MedicineA small clinical trial conducted at WashU Medicine shows promising results for patients with triple-negative breast cancer who r

Updated on:December 02,2024 0

Novel CAR T-cell therapy demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors

byVall d'Hebron Institute of OncologyGeneration and characterization of p95HER2.CART cells. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-53265-7One-third of

Updated on: December 02,2024 0

Novel CAR T-cell therapy demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors

byVall d'Hebron Institute of OncologyGeneration and characterization of p95HER2.CART cells. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-53265-7One-third of

Updated on:December 02,2024 0

Why alarm is easing over a rise in pancreatic cancer among the young

by Robin FosterExperts have been concerned by rising rates of pancreatic cancer in young adults, but new research reveals the jump in cases has not been accompanied by any increase in deaths from the

Updated on: December 02,2024 0

Why alarm is easing over a rise in pancreatic cancer among the young

by Robin FosterExperts have been concerned by rising rates of pancreatic cancer in young adults, but new research reveals the jump in cases has not been accompanied by any increase in deaths from the

Updated on:December 02,2024 0

New microfluidic device shows tumor shape predicts cancer aggressiveness

byUniversity of TorontoThe image shows culture, release and transfer of the tumoroids from the ReSCUE platform, as well as the released breast cancer disk-, rod-, and U-shaped tumoroids cultured

Updated on: December 02,2024 0

New microfluidic device shows tumor shape predicts cancer aggressiveness

byUniversity of TorontoThe image shows culture, release and transfer of the tumoroids from the ReSCUE platform, as well as the released breast cancer disk-, rod-, and U-shaped tumoroids cultured

Updated on:December 02,2024 0

Research concentrates on genes that cause tumors in the Meibomian gland

byTufts UniversityDr. Cornelia Peterson calibrates a piece of equipment used to measure intraocular pressure during an ocular toxicity study in animals. Credit: Noah MossDr. Cornelia Peterson is

Updated on: December 01,2024 0

Research concentrates on genes that cause tumors in the Meibomian gland

byTufts UniversityDr. Cornelia Peterson calibrates a piece of equipment used to measure intraocular pressure during an ocular toxicity study in animals. Credit: Noah MossDr. Cornelia Peterson is

Updated on:December 01,2024 0

Mobile 'Man Van' spots prostate cancer more quickly and cheaply than via GPs

byInstitute of Cancer ResearchCredit: The Man Van and The Royal Marsden NHS Foundation TrustMobile testing "Man Van" can diagnose prostate cancer in at-risk groups earlier and more aff

Updated on: December 01,2024 0

Mobile 'Man Van' spots prostate cancer more quickly and cheaply than via GPs

byInstitute of Cancer ResearchCredit: The Man Van and The Royal Marsden NHS Foundation TrustMobile testing "Man Van" can diagnose prostate cancer in at-risk groups earlier and more aff

Updated on:December 01,2024 0

AI analysis of immune cells can predict breast cancer prognosis

byKarolinska InstitutetDigital image analysis flowchart for classifiers development and utilization. Credit:eClinicalMedicine(2024). DOI: 10.1016/j.eclinm.2024.102928Researchers at K

Updated on: December 01,2024 0

AI analysis of immune cells can predict breast cancer prognosis

byKarolinska InstitutetDigital image analysis flowchart for classifiers development and utilization. Credit:eClinicalMedicine(2024). DOI: 10.1016/j.eclinm.2024.102928Researchers at K

Updated on:December 01,2024 0

Novel selenium carrier protein regulates ferroptosis in tumors and the brain

byTohoku UniversityPRDX6 is a critical regulator of ferroptosis surveillance. As a selenium- acceptor protein, PRDX6 aids in intracellular selenium utilization for efficient selenoprotein biosyn

Updated on: December 01,2024 0

Novel selenium carrier protein regulates ferroptosis in tumors and the brain

byTohoku UniversityPRDX6 is a critical regulator of ferroptosis surveillance. As a selenium- acceptor protein, PRDX6 aids in intracellular selenium utilization for efficient selenoprotein biosyn

Updated on:December 01,2024 0

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring and treatment

byIndiana UniversityIU School of Medicine's Spyridon Bakas said the new recommendations are a much-needed update to the current standard of care in which individual radiologists measure tumo

Updated on: December 01,2024 0

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring and treatment

byIndiana UniversityIU School of Medicine's Spyridon Bakas said the new recommendations are a much-needed update to the current standard of care in which individual radiologists measure tumo

Updated on:December 01,2024 0